Press Releases Archives - Page 9 of 103 - Lupin

BSE 2307.55 NSE 2307.90

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2307.55 NSE 2307.90

Lupin and Avas Launch NaMuscla® in Italy

January 28, 2025

Lupin Receives U.S. FDA Approval for Sacubitril and Valsartan Tablets

January 24, 2025

Lupin Receives Approval from U.S. FDA for Abacavir, Dolutegravir and Lamivudine Tablets for Oral Suspension

January 24, 2025

Lupin Launches Minzoya TM (Levonorgestrel and Ethinyl Estradiol Tablets, USP and Ferrous Bisglycinate Tablets) in the United States

January 13, 2025

Lupin Receives Tentative Approval from U.S. FDA for Ivacaftor Oral Granules

January 9, 2025

Lupin Receives Tentative Approval from U.S. FDA for Loteprednol Etabonate Ophthalmic Gel

January 9, 2025

Lupin Receives EIR from U.S. FDA for its Pithampur Unit-1 Facility with VAI Classification

January 8, 2025

Lupin and Slurrp Successfully Conclude Lupin Aptivate Achchi Bhookh Quiz

January 6, 2025

Lupin Acquires Huminsulin from Lilly to Enhance Diabetes Portfolio

December 30, 2024

Lupin Receives Approval from U.S. FDA for Emtricitabine and Tenofovir Alafenamide Tablets

December 18, 2024

1 2 … 8 9 10 … 102 103

Search

Hit enter to search or ESC to close